Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06760936
Pixantrone as Bridging Therapy to Allogenic Transplant or CAR-T Cell Therapy in DLBCL Patients
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
View on ClinicalTrials.gov
Summary
Retrospective/prospective observational multicentric study aimed at describing the effectiveness of pixantrone as bridging therapy to allo-HSCT or CAR-T therapy
Official title: Pixantrone as Bridging Therapy to Allogenic Transplant or CAR-T Cell Therapy in DLBCL Patients - A Retrospective-prospective Observational Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
15
Start Date
2022-06-06
Completion Date
2025-12-31
Last Updated
2025-01-07
Healthy Volunteers
No
Conditions
Locations (1)
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Italy